EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives

Razan Aburumman iD, Muhammad Saad Faisal, Sumit Singla

Journal of Clinical Medicine · 23.07.2026 · 15 (15) · 5781

DOI: 10.3390/jcm15155781 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.07.2026. Verfasst von Razan Aburumman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma (CCA) is an aggressive malignancy associated with malignant biliary obstruction and it has poor overall survival. Most patients present with unresectable disease which limits curative treatment options and highlights the need for effective palliative therapies. Endobiliary radiofrequency ablation (RFA) has emerged as a minimally invasive technique aimed at reducing intraductal tumor burden, improving biliary drainage, and potentially prolonging survival. Recently, multiple randomized controlled trials, retrospective studies, and meta-analyses have evaluated the role of endobiliary RFA in patients with CCA, with mixed results. Available evidence suggests that RFA may provide a survival benefit in selected patients. However, its effects on stent patency and quality of life remain inconsistent across studies. Current data also demonstrate an overall acceptable safety profile. In this review, we summarize the procedural techniques, currently available evidence, adverse events, patient selection considerations, guideline recommendations, and future directions regarding the use of endobiliary RFA in CCA.

Schlagwörter

Stichwörter der Autor:innen

RFAcholangiocarcinomaendobiliary radiofrequency ablationmalignant biliary obstruction

Autor:innen und Institutionen

  • Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI 48202, USA.

ORCID-Profile: Razan Aburumman

Zitieren

APA

Aburumman, R., Faisal, M. S., & Singla, S. (2026). Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives. Journal of Clinical Medicine, 15(15), 5781. https://doi.org/10.3390/jcm15155781

Vancouver

Aburumman R, Faisal MS, Singla S. Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives. Journal of Clinical Medicine. 2026;15(15):5781. doi:10.3390/jcm15155781

BibTeX
@article{Aburumman2026,
  author = {Aburumman, Razan and Faisal, Muhammad Saad and Singla, Sumit},
  title = {Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {5781},
  doi = {10.3390/jcm15155781}
}
Kostenlos starten →